In a wide-ranging interview with PharmaDispatch, AstraZeneca's Liz Chatwin talks about how the Australian market has changed, the opportunity for industry to be more strategic on key issues, the importance of manufacturing and R&D, and diversity.

Latest Video
New Stories
-
The 'Week in Review' Podcast - 21 February
February 21, 2025 - - Podcast -
PSA members endorse acquisition of the Australasian College of Pharmacy
February 21, 2025 - - Latest News -
Significant gift new Academy for Health Leadership at University of Melbourne
February 21, 2025 - - Latest News -
First and only treatment for chronic hypoparathyroidism approved in Australia
February 21, 2025 - - Latest News -
AstraZeneca maintains its lead as other teams start to build
February 21, 2025 - - Latest News -
A good idea that will need to overcome an institutional mindset
February 19, 2025 - - Latest News -
Pharmaceuticals the latest Trump target for tariffs
February 19, 2025 - - Latest News